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Background: After stimulation of a cell by the mito-
genic epidermal growth factor (EGF), the EGF receptor
(EGF-R) is cleared from the cell surface in order to turn
off receptor signaling. This internalization is mediated via
clathrin-coated pits and coated vesicles, and ultimately
the receptors are delivered to the lysosome and de-
stroyed. It is believed that clathrin-associated protein
complexes or adaptors (APs) link the entrapment of
EGF-R and other nutrient and growth-factor receptors to
the formation of the clathrin-coated pit. Two classes of
APs are known - AP-2, found at the plasma membrane,
and AP-1, found in the trans-Golgi network. Activated
EGF-R associates with AP-2s at the plasma membrane,
but the mechanism responsible for this association is not
known. Here, we investigate, in vivo and in vitro, three
aspects of the interaction between APs and EGF-R:
firstly, we ask whether EGF-R at the plasma membrane
distinguishes between AP-1 and AP-2; secondly, we ask
which part of the receptor's cytoplasmic tail is responsible
for binding; finally, we ask whether autophosphorylation
by EGF-R is essential for the interaction.
Results: We demonstrate that EGF-R displays a selective
association for AP-2 over AP-1 in vivo, and that this
preferential interaction can also be detected using surface
plasmon resonance in vitro. Using a truncated mutant
and a kinase-dead mutant of EGF-R, we show that the
regulatory domain of the cytoplasmic tail is essential
for the recruitment of AP-2 in vivo and that this domain
is required for association between purified AP-2 and
EGF-R in vitro. Finally, we demonstrate, in vivo and in
vitro, that tyrosine auto-phosphorylation by the receptor is
not an essential pre-condition for the recruitment of AP-2.
Conclusions: EGF-R binds selectively to AP-2s, and the
regulatory domain of its cytoplasmic tail is required for
this interaction. The lack of correlation between receptor
autophosphorylation and AP-2 recruitment suggests that
activation of the EGF-R kinase stimulates endocytosis by
the phosphorylation of a factor distinct from EGF-R
itself, as also proposed by others based on experiments
measuring receptor traffic and entrapment.
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Introduction
Two classes of receptors are known to be efficiently
internalized by the clathrin-coated pit/coated-vesicle
pathway (reviewed in [1]). One class includes nutrient
receptors such as the low-density lipoprotein receptor,
the asialoglycoprotein receptor and the transferrin recep-
tor - proteins that internalize rapidly from the cell sur-
face whether their ligands are present or not. The second
class includes growth-factor receptors such as the epider-
mal growth-factor receptor (EGF-R) and the platelet-
derived growth-factor receptor, which must associate
with their ligands in order to be recruited by coated pits.
In many instances, this ligand-induced endocytosis
removes the activated receptor from the cell surface,
resulting in its down-regulation.
The clathrin-associated protein complexes (APs), also
referred to as 'adaptors' or 'assembly proteins', are two
related but distinct heterotetramers: AP-1, specific to the
trans-Golgi network (TGN), and AP-2, specific to the
plasma membrane (see [2,3]). AP-1 contains the large
chains y and 31, the medium chain jIl and the small
chain crl; AP-2 contains the large chains eta or cic and
32, the medium chain [I2 and the small chain u2. APs
promote the assembly of the clathrin lattice [4,5], and are
located between the lattice and the cytoplasmic surface of
the membrane in coated pits and coated vesicles [6,7].
Their location, together with biochemical data [8-11]
showing an association between purified APs and isolated
cytoplasmic tails of receptors that undergo constitutive
traffic, has led to a model in which the recruitment of
both classes of receptors into clathrin-coated pits is medi-
ated by interactions of APs with receptor tails.
The detailed mechanism underlying this traffic through
coated pits is not known, but several ideas have emerged
from in vitro binding studies between receptors and AP
complexes, and from kinetic studies of endocytosis in liv-
ing cells, to explain the specificity of this process. Entrap-
ment of a receptor onto a coated pit might occur because
an AP complex, already localized on the plasma mem-
brane or on the TGN, recognizes and associates with a
sorting signal on the receptor. These signals, found in the
cytoplasmic tails of nutrient and growth-factor receptors
and mostly identified by mutational analysis, typically
consist of four to six amino acids, which do not display
strict sequence conservation (see [1]). The receptor-AP
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interaction would then increase the affinity of AP com-
plexes for cytosolic clathrin, resulting in the rapid assem-
bly of the coat and the eventual capture of the receptor
in a coated vesicle. Alternatively, a receptor that freely
diffuses in the plane of the membrane could interact with
APs already forming coated pits and about to form
coated vesicles.
The recent demonstration that ligand-activated EGF-Rs
located at the cell surface associate with plasma mem-
brane AP-2 complexes - the first example of recep-
tor-AP association in living cells - has enhanced our
understanding of receptor recruitment into clathrin-
coated structures [12,13]. The cytoplasmic tail of EGF-R
contains a membrane-proximal tyrosine kinase and a
membrane-distal regulatory domain of about 230 amino
acids [14]. The regulatory domain has a 48 amino-acid
region, which contains at least three sequences that pro-
vide endocytic signals, and a so-called 'inhibitory
domain' of about 160 amino acids at the carboxyl termi-
nus of the molecule, which contains the autophosphory-
lation sites [14,15]. It is believed that the binding of EGF
to the extracellular part of the receptor leads to receptor
dimerization and stimulation of the tyrosine kinase
domain, allowing trans-autophosphorylation of the
receptor tails [16]. Several tyrosine residues in the
inhibitory domain are phosphorylated after activation
[17-19]. These modifications cause the recruitment of
several proteins, notably Grb-2 and Sos [20], which initi-
ate signal transduction via the Ras pathway. At the same
time, the EGF-Rs, which are normally free to diffuse in
the plane of the membrane, become clustered in coated
pits and are rapidly internalized (see [21]).
It has been proposed that phosphorylation of the
inhibitory domain induces a conformational change,
which allows the endocytic signals within the 48 amino-
acid sub-domain of the regulatory region to interact with
the endocytic apparatus [22]. However, dimerization and
autophosphorylation of the receptor do not appear to be
sufficient to activate EGF-R internalization. For exam-
ple, 'kinase-dead' EGF-R mutants - with an inactive
kinase but an otherwise intact receptor tail - will not
endocytose in response to EGF, although presumably
they can still dimerize [23,24]. Likewise, certain EGF-R
deletion mutants, lacking the autophosphorylation sites
but containing the endocytic signals, are actively inter-
nalized in response to EGF, but only when the receptor
bears an active kinase [15]. Together with studies on the
internalization of other receptors [25-27], these results
suggest that the kinase activity is required to stimulate
receptor endocytosis by the phosphorylation of a target
distinct from the receptor itself.
Here, we show that the EGF-R regulatory domain
containing the endocytic signals is essential for the
recruitment of AP-2 complexes by activated receptors in
living cells. Moreover, we reproduce this association in
vitro, using isolated EGF-R and purified AP-2
complexes. We find that tyrosine autophosphorylation of
EGF-R is not an essential pre-condition for AP-2
recruitment, as a kinase-dead mutant of EGF-R can also
associate with AP-2 complexes both in vivo and in vitro.
Together with the results summarized above, our data are
consistent with the model in which the most important
event required for EGF-R-AP association is the phos-
phorylation of a substrate distinct from either the recep-
tor or the APs. How this second event is linked to
AP-recruitment remains to be determined.
Results
The regulatory domain of the EGF-R is required for the
interaction of the receptor with AP-2 complexes in vivo
We used two procedures to confirm that human EGF-R,
expressed in mouse B82L cells transfected with the
human EGF-R gene, associates with AP-2. In the first, as
described by Sorkin and Carpenter [12], cells were incu-
bated at 4 °C with human EGF to activate the kinase and
to induce receptor autophosphorylation; coated-pit for-
mation and internalization do not occur at this tempera-
ture. The activated cells were then warmed to 37 C to
re-establish endocytosis and to allow association of
EGF-R with AP-2 complexes. Immunoprecipitation of
EGF-R, together with western blotting, indicated that
EGF-R indeed associated with AP-2 complexes and
autophosphorylated (Fig. 1, lanes 1-7). The largest
increase in the strength of the signal (about eight-fold),
corresponding to association with the AP-2 complexes of
the plasma membrane, was usually obtained after 20-60
minutes of rewarming; this increase also corresponded to
association with 1-2 % of the total cellular pool of AP-2
- in agreement with results obtained recently using
mouse NIH3T3 cells that express human EGF-R [13].
In the second procedure, the cells were kept at 37 °C
during the incubation with EGE The results were similar
to those of the first procedure, although a faster rate of
EGF-R-AP-2 association was observed (Fig. 1, lanes
15-21) - more consistent with the known course of
EGF-R internalization in transfected B82L cells [28]. By
contrast, this temperature effect was not seen in Chinese
hamster ovary (CHO) cells transfected with the human
EGF-R gene, where rapid association and dissociation
phases were observed even with pre-cooling (see Fig. 8,
below). The association of AP-2 complexes with EGF-R
was specific, as no bands reacting with anti-a antibody
were detected in control experiments performed with
untransfected mouse B82L cells (Fig. 1, lanes 8-14).
A truncated mutant of EGF-R (c'958), lacking the
regulatory domain and defective in internalization, has
been stably expressed in mouse B82L cells [15]. To inves-
tigate whether this mutant EGF-R can associate with
AP-2, we used both procedures described above. West-
ern-blot analysis of the immunoprecipitates showed that,
after EGF activation, the truncated receptor did not
recruit detectable amounts of AP-2 complexes (Fig. 1,
lanes 22-28). Comparison with the immunoprecipitate
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Fig. 1. Recruitment of AP-2 complexes by EGF-R in vivo requires the regulatory domain of the receptor. Lysates from non-expressor
mouse B82L cells (Control cells) and from transfected B82L cells expressing the intact receptor (EGF-R) or the truncated c'958 receptor
(Truncated EGF-R) lacking its regulatory domain, were immunoprecipitated with the anti-EGF-R antibody, 13A9, and subjected to SDS-
7.5 % polyacrylamide gel electrophoresis (PAGE). Western-blot analysis was carried out using the monoclonal antibodies CHC5.9 spe-
cific to clathrin heavy chain (HC), 4G10 specific to phospho-tyrosine (p-Y) and 291-3A specific to EGF-R, and the polyclonal
antibodies C6 and C8 directed against the AP-2 aa and ac chains, respectively, and anti--y directed against the AP-1 y chain. The lanes
represent a similar number of receptors. Lanes 1-7, cells expressing intact receptor were chilled to 4 C in the (lanes 1,2) absence or
(lanes 3-7) presence of 250 ng m-1 EGF, and then transferred to 37 C for the indicated times. This experiment is representative of 10
carried out. Lanes 8-28, control cells and cells expressing the intact or truncated receptor were kept at 37 C and incubated in the
(lanes 8,9,15,16,22,23) absence or (lanes 10-14,17-21,24-28) presence of 250 ng ml-' EGF for the indicated times. The results are
representative of four experiments.
samples from control cells (Fig. 1, lanes 8-14) indicated
that there was a small amount of ot signal constitutively
associated with the truncated receptor. This association
may reflect some interaction between AP-2 complexes
and the remaining portion of the cytoplasmic tail of the
truncated EGF-R. Alternatively, it may indicate an inter-
action of AP-2 with other proteins that co-immunopre-
cipitate with EGF-R. For example, a protein of
-190 kDa (probably erb2/neu) becomes tyrosine-phos-
phorylated in response to EGF and is found in co-
immunoprecipitates with EGF-R [14]. From our
experiments in vivo, we conclude that the regulatory
domain is important for the EGF-dependent interaction
of EGF-R with AP-2.
The data in Figure 1 also show that, in the mouse cells,
AP-1 is not recruited by activated EGF-R (probed for
using an anti-y antibody). Given the sensitivity of the
western blots, a low level of association is possible, but it
would be less than -0.1 % of the cellular pool of AP-1
complexes. In agreement with published results [12],
clathrin was not recruited by the activated EGF-R (even
though the receptor was associated with AP-2 com-
plexes), suggesting that the immunoprecipitates might
derive from a step that precedes coated-pit formation.
Under the buffer conditions used for immunoprecipita-
tion, clathrin and APs not only remain attached to coated
vesicles but also interact efficiently with each other to
form coats (our unpublished observations) - any clathrin
associated with EGF-R-AP-2 would not have been lost
on isolation.
AP-2 complexes contain either an axa or an c large
chain [29]. Western-blot analysis of the immunoprecipi-
tates of EGF-R and of APs from aliquots of EGF-acti-
vated cell extracts indicated no preferential interaction of
Fig. 2. AP-2 complexes recruited by EGF-R in vivo contain aa
and ac chains. Mouse B82L cells expressing intact EGF-R were
incubated at 4 C with 250 ng ml-1 EGF and then transferred for
10 min to 37 C. The cells were returned to 4 C, lysed with
TGH buffer and the lysates divided into aliquots for immunopre-
cipitation, SDS-7.5 % PAGE and western-blot analysis. Immuno-
precipitates were obtained with the serum 31 directed against the
ac chain of AP-2 (lane 1), with the antibody 13A9 against EGF-R
(lane 2), and with the serum 32 against the 31 and B2 chains of
the AP-1 and AP-2 complexes (lane 3). The membrane was
immunoblotted with the antibody AC1-M11 specific for the a
and cac chains of AP-2.
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EGF-R with either the ota or the oc class of AP-2 com-
plexes. Both ao chains were present in AP-2 bound to
EGF-R (Fig. 2, lane 2), although the ratio of aa and ac
might be slightly different than the total cellular sampling
of AP complexes (Fig. 2, lane 3). The absence of oa sig-
nal in the immunoprecipitate with the anti-ac serum
(Fig. 2, lane 1) confirmed that only one type of a chain
is present in a given AP-2 complex. We conclude that
activated EGF-R binds AP-2 selectively in vivo, but with
no preference for aoa or ac.
Isolated EGF-Rs preferentially associate with purified AP-2
and not with AP-1 in vitro
Can the specific association between EGF-R and AP-2
complexes detected in vivo be reproduced in vitro using
isolated molecules? We chose to use surface plasmon res-
onance (SPR) detection experiments performed in real-
time with the BIAcoreTM apparatus to develop an in vitro
method for detecting such interactions. EGF-Rs from a
Triton X-100 extract of the transfected mouse B82L
cells were adsorbed to the surface of a BIAcoreTM sensor
chip that contained chemically cross-linked monoclonal
antibody 13A9 - specific for the extracellular domain of
the receptor. The recruitment of the receptors onto the
surface of the sensor chip, monitored as an increase of
resonance units (RU), was found to be completely
dependent on the presence of the anti-EGF-R antibody
(Fig. 3a-d). The binding reached steady-state after
1200 seconds and was saturable - there was no further
increase in the signal after another injection of lysate
(data not shown). Given that the RU signals are propor-
tional to the mass of protein bound to the sensor chip,
and that the antibody molecules are dimeric, we estimate
that one molecule of EGF-R monomer was bound per
four molecules of divalent antibody. This figure is likely
to represent an overestimate of the antibody-binding
capacity of the chip, as we did not take into account the
added mass of EGF-R due to its glycosylation or to the
Triton X-100 micelle attached to it. A similar lysate,
obtained from control cells, generated a much smaller
signal (less than 5 %; Fig. 3a).
To regenerate the surface of the sensor chip and to
restore the capacity of the chip to adsorb fresh EGF-R,
bound EGF-Rs were eluted from the cross-linked anti-
bodies with a brief flush of high pH solution containing
a small amount of SDS. As shown in Figure 3e, the signal
returned to the level seen before the recruitment of
EGF-R, and several cycles (10-20) could be carried out
before the receptor-binding capacity of the chip declined
significantly. This procedure of specific retention, starting
from a crude cell extract, has, to our knowledge, not
been used before. It provides, in effect, a single efficient
step of purification.
Full-length human EGF-R immobilized in this way
specifically recruited purified bovine AP-2 complexes
(Fig. 4a). Evidence to support the specificity of this asso-
ciation included the lack of AP-2 binding in the absence
of EGF-R (Fig. 4a), and other controls such as the lack
of BSA binding to immobilized EGF-R and the failure
of BSA to compete with AP-2 binding to EGF-R when
simultaneously presented to the receptor at -2 mg ml-1
(data not shown). The results from this experiment were
Fig. 3. Detection of EGF-R from cell lysates
by real-time SPR. (a-d) Specificity of
receptor recruitment. Cell lysates from (a,c)
control B82L cells and (b,d) B82L cells that
express intact EGF-R were injected through
a sensor chip (a,b) containing immobilized
antibody 1 3A9 specific for the extracellu-
lar domain of EGF-R or (c,d) in the absence
of antibody. The surface plasmon reso-
nance units (RU) were recorded as a func-
tion of time (sensogram). The sharp change
in RU at the beginning and end of the sam-
ple injection reflects changes in refractive
index between the sample and flow buffer.
(b) -2700 RU of EGF-R were captured by
the immobilized antibody; (a,c,d) in the
control experiments only 100 RU were
retained. At -1000 seconds, bound pro-
teins including APs and EGF-R were
released by a flow of 10 mM NaOH, 0.5 %
SDS. Similar non-specific association was
obtained with the truncated receptor (data
not shown). (e) Regeneration of the sensor
chip. The sensograms correspond to three
consecutive cycles of EGF-R capture by the
sensor chip from a lysate of B82L expressor
cells, followed by their complete release
(regeneration) using a short pulse of
10 mM NaOH, 0.5 % SDS starting at
-850 sec. A total of 800 RU were bound
and released in each cycle.
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Fig. 4. The regulatory domain of isolated EGF-R is required for the interaction of the receptor with purified AP-2 complexes. (a) Overlay
plot of three sequential sensograms. Firstly, intact EGF-R was captured on the sensor chip. Injection of the cell lysate was followed by a
1200 sec wash with extraction buffer and a 480 sec injection of 32 pIl purified AP-2 complexes (0.3 mg ml-1; flow of 4 .1I min- 1). After
a final 300 sec wash with extraction buffer, the sensor chip was subjected to regeneration, to remove bound EGF-R and APs, as
described in Fig. 3. The sharp vertical rises at the beginning and the end of the injections reflect a change in refractive index due to dif-
ferences in buffer composition. The relative responses corresponding to specific AP-2 association were recorded as the difference in
RU reading before (arrow 1) and after (arrow 2) the AP-2 injections. The second sensogram was started by the capture of truncated
EGF-R, followed by a cycle of AP-2 injection and regeneration. The third sensogram was recorded with a lysate from control cells. (b)
The expansion of the overlay plot reveals that AP-2 complexes associate with intact EGF-R but not with the truncated EGF-R or with the
lysate from control cells.
reproducible and were repeated several times using inde-
pendent sensor chips, with different AP-2 preparations
and with extracts from several transfected cell lines that
overexpress EGF-R - mouse B82L, CHO and Sf9
insect cells (summarized in Fig. 5) and human carcinoma
A431 cells (data not shown).
It is likely that most of the detected signal represents
AP-2 directly bound to EGF-R rather than through an
intermediate protein. Three observations support this
deduction. Firstly, the -170 kDa band of the receptor
was by far the most prominent one revealed by SDS-
PAGE and Coomassie-Blue staining of EGF-R immuno-
precipitates obtained using the same lysis and buffer
conditions (data not shown). Secondly, EGF-R produced
in transfected insect Sf9 cells also recruited AP-2. It
would be necessary to argue that these cells, which over-
express human EGF-R at very high levels, also contain
Fig. 5. Relative association of AP-1 and AP-2 to intact and mutant EGF-Rs. The bars represent RU readings for bound AP-1 or AP-2
complexes to intact EGF-R, truncated EGF-R and kinase-dead EGF-R as monitored by SPR in 16 independent experiments. Intact EGF-R
was expressed in B82L, CHO and Sf9 insect cells. The truncated and kinase-dead receptors were expressed in B82L and CHO cells,
respectively. The amount of receptor bound to the sensor chip ranged between 1630-2850 RU. Within individual experiments, RU
readings for AP-1 and AP-2 were adjusted by the ratio in molecular weight of the intact and the truncated receptor. The lysates for
experiments 1-4 were from cells stimulated with 250 ng ml 1 EGF; remaining lysates were from non-stimulated cells. Individual exper-
iments were performed with independent AP-1/AP-2 preparations: experiments 1-3, at -0.3 mg ml-1; 4-6,15,16, at -0.3 mg ml-'; 7, at
-0.3 mg ml-'; 8, at -1 mg ml-1; 9-13, at -1 mg ml- 1; 14, at -1 mg ml-1 .
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EGF-R by the immobilized antibody had a kon in the
range of 105-106 M-lsec -1 , The release of bound AP-2
complex was too slow to be measured, In contrast,
EGF-R recruited by the antibody dissociated with an
estimated half-time of 10-15 hours (data not shown).
Tight association is also displayed by AP-2 complexes in
immunoprecipitates of EGF-R obtained from lysates of
cells incubated with EGF before disruption, where the
amount of AP-2 co-precipitating with EGF-R is the
same 20 minutes or 4 hours after lysis (data not shown
and [13]),
Under the conditions used, recruitment of AP-2 by
EGF-R reached saturation at -1.0 mgml - l AP-2
(Fig. 6), and up to approximately one mole of AP-2
complexes were captured per six moles of immobilized
EGF-R. These values are similar to the recruitment of
one mole of EGF-R by four moles of chemically immo-
bilized antibody (see above). The 1:4 to 1:6 ratios appear
tn Pflrct ntirentninn nAl ac c.chilnrr f xtr ,Xhepn ¢lcnh
Fig. 6. Binding of purified AP-2 complexes to isolated EGF-R is
saturable. Purified AP-2 complexes at different concentrations
were tested for binding to similar amounts of intact EGF-R and
truncated EGF-R receptor bound to the sensor chip.
Specifically bound AP-2 is expressed as ARU. This value is the
difference in RU reading before and after injection of AP-2s
(arrows 1,2 in Fig. 4) corrected for the small variation (< 10 %)
in the amount of bound receptor in each experiment, for the
constant release (3-10 U min-) of bound receptor from the
antibody and for the non-specific interaction (< 5 %) obtained
with the control cell lysate.
such a putative adaptor molecule. Thirdly, in vivo, AP-2 is
in direct contact with EGF-R with an approximate 1:1
stoichiometric relationship.
The rates of association and dissociation for AP-2 and the
immobilized receptor were noticeably different. The
association phase approached steady-state values after
180-360 seconds of AP-2 injection, and the association-
rate constant (ko,) was in the range of
1-3 x 103 M- 1 sec-1 using AP-2 concentrations up to
1.3 mg ml- (-5 txM). By comparison, the capture of
large molecules are bound to the dextran coating of a
sensor chip.
As EGF-R shows selective association with AP-2 over
AP-1 in vivo, we asked whether this differential selectivity
would also be maintained in vitro using isolated
molecules. Purified AP-1, in the same amount and con-
centration as AP-2, was used to test its capacity to inter-
act with full length EGF-R. The amount of AP-1
specifically retained by EGF-R in the sensor chip was
negligible and similar to the amount which bound to
lysates of control cells (Figs 5,7), This result is consistent
with the minimal association of AP-1 and EGF-R
observed in vivo (Fig. 1). The preferential binding of AP-
2 detected by SPR is a good indication that the observed
association is specific, because the biochemical properties
of AP-1 and AP-2 are otherwise very similar (see [3]).
The regulatory domain of EGF-R is required for association
of the receptor with purified AP-2 complexes in vitro
As the truncated receptor c'958 is markedly impaired in
its ability to associate with AP-2 complexes in vivo, we
(a) Cell lysate Buffer AP-1 Buffer (b) AP-1
~ ~ ~--~' ~'~-> ~< 3000- 
20500
EGF-R 2500-
- - 1 2 ~ 2000
RU 1 RU
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Fig. 7. Interaction between AP-1 and isolated EGF-Rs is weak. (a) Overlay plot of three sensograms, obtained as described in Fig. 4 and
representative of five other experiments. Similar amounts of intact EGF-R and truncated EGF-R were used to probe the interaction with
purified AP-1 complexes (0.3 mg ml-1). (b) The expansion of the overlay plot illustrates the absence of detectable association of AP-1
with the intact EGF-R.
I-L
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expected that it would also fail to interact with purified
AP-2 in vitro. Experiments performed using SPR
detection confirmed this prediction (Fig. 5, experiments
1-11). An example of an SPR trace showing the absence
of specific association between purified AP-2 complexes
and the truncated receptor is shown in Figure 4. The
extent of binding was comparable to the association
detected with the lysate of control cells. Furthermore, no
significant association between the truncated receptor
and purified AP-1 complexes was detected (Fig. 7). The
regulatory domain of the EGF-R is therefore required,
both in vivo and in vitro, for the selective recruitment of
AP-2 complexes.
Phosphorylation of EGF-R is not essential for association
with AP-2
It has been proposed, based on endocytosis experiments,
that upon autophosphorylation, the cytoplasmic tail of
EGF-R undergoes a conformational change and that this
change results in the exposure of endocytic signals, lead-
ing to internalization of the receptors [22]. Sorkin and
Carpenter [12] found, however, that EGF-R from cells
blocked in endocytosis due to K depletion [30-32]
recruits AP-2 even in the absence of EGF activation and
EGF-R autophosphorylation. This result suggests that
autophosphorylation of the receptor may not be essential
for AP-2 recruitment. To test this possibility in vitro, we
compared the capacity of AP-2 to bind EGF-R with
different levels of autophosphorylation obtained by
pre-treating the cells with EGF prior to lysis. We found
that activation with EGF had no effect on the level of
AP-2 binding (Fig. 5, experiments 1-4). We also
increased the phosphorylation of EGF-R after capture on
the sensor chip, by the addition of 5 mM Mn 2C12 and
1 mM ATP to activate the receptor kinase [33,34], or
decreased the phosphorylation by the addition of calf-
intestine alkaline phosphatase [35]. No effect on the
binding of crude APs or of purified AP-2 was detected,
even though the receptor phosphorylation varied -
monitored by the differential binding to an antibody
specific for phospho-tyrosine (data not shown).
While this paper was being revised, Nesterov and
colleagues [35] published experiments on the association
of EGF-R with crude APs, using an SPR approach
similar to the one described here. In their work, they
found that phosphorylation of EGF-R in vitro correlated
with increased AP binding. The conditions of their
experiments were different from ours: for example, APs
tend to self-associate in the buffer they used. In any case,
we demonstrate below that phosphorylation is not
essential for AP recruitment by EGF-R in vivo. We
therefore believe that the characteristics of the isolated
receptor studied here correspond well to its properties in
a physiological context.
As a complement to the experiments described above,
we asked whether a kinase-dead receptor, unable to
autophosphorylate, would nevertheless recognize AP-2.
To answer this question, we compared the association in
vitro of AP-2 with wild-type EGF-R and with the
EGF-R R721 mutant lacking phosphorylation activity
due to the conservative substitution Lys-4Arg 7 21 in its
kinase domain [24]. We found that this EGF-R mutant
bound AP-2 just as well as wild-type EGF-R (Fig. 5,
lanes 12-14).
Fig. 8. Detection of AP-2 complexes associated with kinase-dead EGF-Rs in vivo. (a) Lysates from control CHO cells and from
transfected CHO cells expressing intact EGF-R or the point mutant R721 with no kinase activity (kinase-dead EGF-R) were immunopre-
cipitated with the anti-EGF-R antibody 13A9 and subjected to SDS-7.5 % PAGE. The western-blot analysis, representative of three
experiments, was done with antibodies against phosphotyrosine, EGF-R and the AP-2 a and c chains. The cells were incubated at
4 C in the absence (lanes 1,2,8,9,15,16) or presence (lanes 3-7,10-14,17-21) of 250 ng ml-1 EGF for 60 min and then transferred to
37 C for the indicated times. (b) Cells were left untreated (lanes 1-6) or depleted of K+ (lanes 7-12) for 30 min at 37 °C. Incubation of
the cells without (lanes 1,3,5,7,9,11) or with (lanes 2,4,6,8,10,12) 250 ng ml-1 EGF for 10 min at 37 C was followed by receptor
immunoprecipitation, SDS-7.5 % PAGE and western blot analysis. The relative strengths of the phosphotyrosine signals were:
(lanes 1-6) 0, 0, 23, 67, 1 and 2 %, respectively; (lanes 7-12) 0, 0, 51, 35, 1, and 1.7 %, respectively. The relative strengths of the
aa/cc signals were: (lanes 1-6) 2, 6, 11, 34, 18 and 29 %, respectively; (lanes 7-12) 2, 2, 22, 43, 12 ,and 19 %, respectively. These
values were obtained by incubation with the appropriate primary antibodies followed by 1125-protein A and Phosphorimager analysis.
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We also studied, in vivo, the capacity of the kinase-dead
EGF-R mutant to interact with AP-2 in transfected
CHO cells (Fig. 8). The results from the temperature-
shift experiment (Fig. 8a, lanes 15-21) demonstrate that
the kinase-dead EGF-R can indeed associate with AP-2
in response to EGF. However, the strength of the AP-2
signal was approximately 6-8 fold lower than with the
wild-type receptor (Fig. 8a, lanes 8-14). In contrast, AP-
2 associated with the intact and the kinase-dead receptor
to almost the same degree when the cells were kept at
37 C (sampled after 10 minutes of EGF incubation; Fig.
8b, lanes 4,6). The phosphorylation signal, however, was
approximately 28 fold higher for the intact receptor that
it was for the sample containing the kinase-dead recep-
tor. It is therefore unlikely that the phosphotyrosine
cross-reactive band seen with the kinase-dead receptor
can account for the observed AP-2 association. The
requirement for active kinase can also be circumvented
by K+ depletion even in the absence of EGF (Fig. 8b,
lanes 3-6). Thus, depending on the conditions used in
vivo, there is an efficient association of AP-2, even when
the kinase activity of EGF-R is not intact.
Discussion
The co-immunoprecipitation experiments and in vitro
binding studies using SPR reported in this paper show
that EGF-R associates preferentially with AP-2 and not
with AP-1. The in vitro association, therefore, reproduces
the specificity observed in vivo. The interaction between
EGF-R and AP-2 requires the regulatory domain of
EGF-R (Fig. 9). Earlier work in vivo showed that the reg-
ulatory domain of EGF-R is required for EGF-induced
internalization from the cell surface [15]. The correlation
reported here shows that the regulatory domain of the
receptor is essential for the interaction with AP-2, as the
truncation of the receptor to residue 958, which abol-
ishes its EGF-induced internalization, also abolishes its
capacity to interact with AP-2. Similar immunoprecipita-
tion results were obtained recently with EGF-R trun-
cated to residue 973, another mutant that also fails to
internalize in response to EGF [13,35]. Likewise,
immunoprecipitation of the related neu proto-oncogene
product HER2, a constitutively internalized cell-surface
tyrosine kinase, demonstrates an association with AP-2 in
vivo [36]. The portion distal to the kinase domain is
required, as its removal abolishes both internalization and
AP-2 interaction. Therefore, it could be argued that the
loss of ability of the receptors to interact with AP-2
accounts for this failure to endocytose.
At least three different sequences in the regulatory
domain of EGF-R have been shown to serve as internal-
ization signals for this receptor [15]; it remains to be
determined whether all participate in independent AP
interactions. None of these signals bear a strong resem-
blance to those in other receptors such as the so-called
'NPXY motif', in which a conserved tyrosine is critical
for endocytosis (see [1]). This diversity of internalization
Fig. 9. Representation of the interaction of AP-2 with EGF-R.
AP-2 association with EGF-R requires the regulatory domain of
the receptor. In this model, their interaction precedes the recruit-
ment of clathrin by AP-2 which is necessary to form the coated
pit. AP-2 contains the large chains a and 2, with the medium
chain 1.2 and the small chain 2 positioned within the AP-core.
EGF-R contains on its cytoplasmic tail the kinase domain fol-
lowed by the regulatory domain. The three known endocytic
sequences of EGF-R are located in the regulatory domain and are
distinct from the tyrosine auto-phosphorylation sites.
signals suggests a multiplicity of targets. There seems,
however, to be little heterogeneity in the AP-2 complex
itself. Although there are two closely related ax chains
[29], we have detected no preferential association of
either class of AP-2 with EGF-R.
AP complexes may bear a number of distinct sites for
interaction with receptor tails, perhaps on more than one
polypeptide chain. At least one such site appears to be
located in the AP core, the portion of the complex that
contains the amino-terminal portions of the ox and 3
chains, together with the medium and small chains
[37,38]. AP-2 cores generated by limited proteolysis of
EGF-R-AP-2 immunoprecipitates from cell lysates
remain associated with EGF-R [12]. Moreover, AP-2
cores are retained on a column containing the recombi-
nant tail of lysosomal acid phosphatase, a lysosomal
enzyme trafficked in coated vesicles [11]. It has also been
demonstrated that the amino-terminal portion of isolated
132 chains of AP-2 interact with the tail of the asialoglyco-
protein receptor [10], and that recombinant o and 32
chains of AP-2 can also interact with EGF-R [35]. There
is recent evidence, using the yeast two-hybrid system, that
isolated R1 and 2, the medium chains of AP-1 and AP-
2, interact with the six-residue, tyrosine-based internaliza-
tion signal of TGN-38 - a protein normally resident in
the TGN, which traffics between the plasma membrane
and the TGN [39]. Clearly, more studies will be necessary
to define the details of these interactions, but it is possible
that multiple interactions, each relatively weak, could
permit combinatorial regulation of receptor traffic.
What is the role of the EGF-R kinase activity in the
recruitment of AP-2? It has been proposed that phospho-
rylation of the receptor itself acts to regulate endocytosis
of EGF-R directly, by inducing a conformational change
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in the carboxy-terminal part of the regulatory domain
[15]. This conformational change is postulated to relieve
inhibition and thereby allow presentation of the internal-
ization signals to the endocytic apparatus. This model
appears to be supported by the observation that the
EGF-dependent association of EGF-R with AP-2 in vivo
is enhanced by receptor kinase activity (our data and
[35]) as well as by presence of the tyrosine autophospho-
rylation sites [35], which are distinct from the non-
phosphorylated internalization signals [14,15].
A number of other observations indicate, however, that a
simple conformational change may not be the only sig-
nificant event for AP-2 recruitment. It is possible to
uncouple the association of EGF-R with AP-2 from the
phosphorylation state of the receptor, both in vivo and in
'vitro ([12,13] and this work). We have shown that the
kinase-dead receptor retains a capacity to recruit AP-2 in
an EGF-dependent manner in vivo; this recruitment can
be almost as high as with the wild-type receptor. Cells
depleted of K+, a condition known to retain AP-2 at the
plasma membrane but to inhibit EGF-R endocytosis
[12,32], show clear association of AP-2 with wild-type
and with kinase-dead EGF-R. This association is
detected even in the absence of EGF and hence of EGF-
induced receptor dimerization and phosphorylation. Fur-
thermore, we show here by SPR that variations in the
level of phosphorylation (induced either by pre-treat-
ment of cells with EGF before lysis or by using the
kinase-dead EGF-R) have no systematic effect on the
extent of AP-2 recruitment by EGF-R. Likewise, in vitro
phosphorylation or dephosphorylation of EGF-R by
treatment with Mn2+/ATP or calf-intestine alkaline
phosphatase had no detectable effects on its interaction
with AP-2 (data not shown). Taken together, these
results suggest that the behavior of the isolated receptor
resembles that found in vivo, including under conditions
of K+ depletion. Moreover, they suggest that a simple
change in tail conformation is not sufficient to explain
the increase in AP-2 affinity displayed by EGF-R upon
activation with EGE
Our data are consistent with the alternative model that
invokes an indirect effect of the receptor kinase activity
on the regulation of EGF-R endocytosis. In this model,
the receptor kinase acts indirectly by the modification of
an internalization component, which stimulates endocy-
tosis by facilitating transfer to the endocytic apparatus,
presumably AP-2 [23]. Two sets of additional results sup-
port this view. First, certain EGF-R mutants, from which
the inhibitory domain (including all the auto-phosphory-
lation sites) has been deleted, still show EGF-dependent
endocytosis if their kinase activity is intact. In contrast,
these mutants fail to internalize in response to EGF if
they also lack kinase activity [14,15]. Second, recent data
on the endocytosis of the insulin, transferrin and asialo-
glycoprotein receptors [27] have demonstrated that a an
additional component(s) is required (probably not APs)
and that the activity of this component is influenced by
the level of cellular kinases [25-27].
What stage of internalization is represented in the co-
immunoprecipitate of EGF-R and AP-2? We have con-
firmed the observation [12] that there is no detectable
clathrin in the EGF-R-AP-2 complex and we therefore
suggest that co-immunoprecipitation detects a step of
association prior to the attachment of clathrin by AP-2
and the formation of a coated pit. The buffer conditions
used do not lead to coat disassembly and, in fact, they
can be used to drive the formation of clathrin-AP-2
coats in vitro. Also, as indicated above, EGF-R recruits
AP-2 in cells in which endocytosis has been blocked by
K+ depletion. In such cells, very little clathrin is detected
on the plasma membrane, although AP-2s are still local-
ized there, as in untreated cells [32].
Finally, we believe that the in vitro results presented here
represent an important technical development in studies
concerning the relatively weak interactions between APs
and receptor tails bearing internalization signals. Use of
SPR should now permit the dissection of the multiple
signals and the identification of their individual targets.
The ratio of bound AP-2 to immobilized EGF-R (up to
1:6) is a vast improvement over methods such as column-
affinity chromatography, where ratios of about 1:10 000
were found using peptide tails of the 46 kDa mannose-6-
phosphate receptor and of the lysosomal acid phosphatase
precursor [11].
Conclusions
A specific interaction between the EGF-R and AP-2 can
be detected in vivo by immunoprecipitation and in vitro
by SPR. In both cases, the regulatory domain of the
EGF-R cytoplasmic tail is required for association.
Autophosphorylation is not essential, however, in vitro or
in vivo. We suggest that the requirement of an active
receptor kinase for endocytosis, as observed by others,
can best be explained by postulating that phosphorylation
of a substrate other than EGF-R itself results in stimula-
tion of receptor uptake. One striking property of the
AP-2-EGF-R complex is its stability, as followed by SPR
- we have not been able to measure dissociation. It is
possible that, in vivo, a further protein participates in
release of the receptor from AP-2.
Materials and methods
Materials
The monoclonal antibodies ACI-M11 (specific for the a and
cac chains of AP-2) and B1M6 (specific for 31 and 32 of AP-1
and AP-2) and polyclonal antibodies C6 (specific for aa), C8
(specific for oc), and anti-y (specific for the hinge-region and
amino terminus of y chains) were gifts of M. Robinson (Uni-
versity of Cambridge). The monoclonal antibody 4G10 against
phosphotyrosine was a gift of T. Roberts (Dana-Farber Cancer
Institute). The monoclonal antibody 13A9 (specific for the
extracellular region of the human EGF-R) was a gift of B.
Fendly (Genentech). The monoclonal antibody 291-3A (spe-
cific for the intracellular domain of the human EGF-R) was
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provided by K. L. Carraway III (Harvard Medical School). The
rabbit serum 31 (specific for otc chains) immunoprecipitates
AP-2 complexes, whereas the serum 32 (specific for 3 chains)
immunoprecipitates both AP-1 and AP-2 complexes [13].
Mouse B82L cells, expressing the intact human EGF-R or the
truncated form c'958 lacking its regulatory domain, and the
control cells transfected with the dihydrofolate reductase gene
were a generous gift of G. Gill (University of California, San
Diego). CHO cell lines, expressing the intact human EGF-R
or the kinase-dead EGF-R mutant R721 (Lys-Arg7 21 ) were
generous gifts of R. Davis (University of Massachusetts).
Media and bovine sera were from GIBCO; glutamine,
methotrexate and bovine serum albumin (BSA; Fraction V)
from SIGMA; Serum Plus and antibiotics from JRH Bio-
sciences; recombinant human EGF from UBI; protein A-
Sepharose from Pharmacia. Horseradish-conjugated antibodies
to mouse IgG (Amersham) and rabbit IgG (Boehringer
Mannheim), nitrocellulose membranes (Schleicher & Schuell)
and enhanced chemiluminescence reagents (Amersham) were
used for immunoblots.
Tissue culture
Cells were cultured at 37 C, 100 % humidity and 5 % CO,
with 2 mM glutamine and 100 U ml- 1 penicillin/0.1 mg ml-T
streptomycin. Control B82L cells were grown in Dulbeccos
Minimal Essential Medium (DMEM) with 5 % calf serum and
the human EGF-R-transfected B82L cells in DMEM with 5 %
dialyzed fetal bovine serum (FBS) and 500 nM methotrexate.
CHO-K1 cells (ATCC) were grown in c--Minimal Essential
Medium (--MEM), 5 % FBS and 5 % Serum Plus. The trans-
fected CHO cells were maintained in c--MEM, 10 % dialyzed
FBS and 200 RpM methotrexate. Before use, the cells were
expanded in non-selecting media for one or two passages.
Association of EGF-Rs with APs in living cells
Cells were grown to confluency in 100 mm dishes and serum-
starved in DMEM (B82L lines) or oe--MEM (CHO lines) con-
taining 0.1 % BSA for 24 h. EGF-Rs were activated [12] with
the following modifications. The dishes were transferred to
4 C in the same media (pre-chilled) and incubated with
+ 100-250 ng mn-1 (16-40 nM) human EGF for 60 min fol-
lowed by transfer to 37 C for various times in the absence of
EGF. Alternatively, cells were kept at 37 C during stimulation
with 250 ng mlM1 EGF and then returned to 4 C by two
sequential washes with chilled PBS. Cells were lysed with
0.7 ml TGH lysis buffer (50 mM HEPES pH 7.3, 10 % glyc-
erol, 1 % Triton X-100, 1 mM Na 3VO 4, 0.5 mM PMSF,
20 .M leupeptin). After 10 min at 4 C, the cells were
scraped, vortexed and lysates cleared by centrifugation at 4 °C
(15 min at top speed in an Eppendorf centrifuge). The K+-
depletion experiments were performed at 37 C [40].
Immunoprecipitations
10 l m-1 antibody 13A9 (1.6 mg ml-1) was added to lysates
and incubated with constant inversion at 4 C for 90 min.
45 I1 m1-1 protein A Sepharose beads, previously blocked with
BSA were then added and incubation continued for another
90 min at 40C. Alternatively, the same amount of antibody was
pre-immobilized to protein A-Sepharose beads in PBS/0.1 %
Triton X-100 at 4 C for 60 min on a rocking platform and,
after two washes with chilled PBS, added to the lysates for
60 min at 4 C. The immunoprecipitates were washed once
with TGH and once with TGH/100 mM NaCI, boiled in
Laemmli buffer with 2.5 % -mercaptoethanol and resolved by
SDS-7.5 % PAGE. For each experiment, it was verified that all
immunoprecipitated samples had the same amount of EGF-R.
Immunoblotting
Proteins, electro-transferred onto nitrocellulose membranes,
were probed with primary antibodies by overnight incubation
at 4 C, or 4 h at room temperature. Secondary antibodies,
conjugated to horseradish peroxidase, were added for 60 min at
room temperature and the signals developed for enhanced
chemiluminescence. Several film exposures with the same blot
and serial dilutions of the same sample were used to be in the
linear range of sensitivity. Specificity and sensitivity of the
immunoreactive signals were verified by analysis of cell lysates
and purified bovine-brain APs. Additional experiments, not
shown here, using 1125-protein-A to probe the nitrocellulose
blots or secondary antibodies conjugated to alkaline
phosphatase, after protein transfers onto PVDF membranes,
gave identical results.
Purification of clathrin-associated protein complexes AP- 1
and AP-2
AP-1 and AP-2 complexes were obtained from crude bovine
brain APs [41] by hydroxyapatite ion-exchange chromato-
graphy [5] as follows. Crude APs, dialyzed at 4 C against
10 mM NaH2PO 4 pH 7.1, 100 mM NaCl, 0.1 % 3-mercap-
toethanol, 0.02 % NaN 3, were applied to a 5 ml hydroxyap-
atite column (Econo-Pac® HTP Cartridge, Bio-Rad)
connected to an FPLC system (Pharmacia) equilibrated in the
same buffer. AP-1 and AP-2 were resolved at 0.5 ml min - 1
using a 40 ml gradient ranging from 10-350 mM NaH 2PO4.
BlAcorerM amine coupling of antibody
Surface plasmon resonance (SPR) detection experiments were
performed with the BIAcoreTM apparatus at 25 C using CM5-
research grade sensor chips (Pharmacia Biosensor). 32 .1l anti-
body 13A9 (80 ,ag ml- ' in 10 mM sodium acetate pH 5.0) at a
flow of 5 l min- 1 was cross-linked by its primary amine
groups to the carboxymethylated dextran surface of the sensor
chip according to the manufacturer (Pharmacia Biosensor). The
resonance signal increased by 8000-9000 RU (- 500 nM) [42].
Binding of EGF-Rs to antibodies immobilized onto the
sensor chip
Cells were grown to confluency on 150 mm dishes, washed
with chilled PBS and lysed with 0.3 ml extraction buffer
(20 mM HEPES, 150 mM NaCl, 1 mM EGTA, 1 % Triton
X-100 pH 7.4) supplemented with 1 mM Na 3VO4 , 0.5 mM
PMSF, 1 mg mnl- leupeptin and 1 mg ml-1 aprotinin. The cells
were scraped and cleared at 4 C by sequential centrifugation at
top speed for 15 min (Eppendorf centrifuge) and at 85 000 rpm
for 30 min (100.4 rotor, Beckman TLX). 40 ml cleared lysate
was injected into the BIAcoreTM apparatus at 2 ml min -1. The
EGF-Rs only adsorbed to sensor chips containing the anti-
EGF-R antibody 13A9. The increase in resonance signal fol-
lowing injection of the lysate of transfected or non-transfected
cells was in the range of 1500-3000 RU and 100-300 RU,
respectively. Because of dissociation of EGF-Rs from the anti-
bodies, there is a baseline drift in the range of 3-10 RU min-.
Injection of purified AP- 1 and AP-2 complexes to the
sensor chip
AP-1 or AP-2 complexes (- 0.3 mg ml- l) were supplemented
with Triton X-100 to prevent aggregation (0.4 % for AP-1 and
0.1 % for AP-2) and dialyzed overnight against AP-binding
buffer (100mM NaMES, 150mM NaCl, 1 mM EGTA,
0.5 mM MgC12, 0.02 % NaN 3, 0.2 mM DTT, and 0.4 or 0.1 %
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Triton X-100 pH 7.0). AP-2s were concentrated 4-5 fold to a
final concentration of 1.3 mg ml1- using a Centriprep-30 unit
(Anmicon). After a high-speed centrifugation step (85 000 rpm,
30 min, 4 C; 100.4 rotor), 32 p.1l of the supernatant were
injected at a flow of 2-4 I.1 min- . Binding was determined by
the increase in resonance signal at the end of each injection rel-
ative to the baseline signal before injection. AP-I and AP-2
association by lysates from expressor cells was corrected from
the signal elicited by the corresponding control cells.
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